Vorasidenib: Revision history

10 April 2025

• curprev 22:2122:21, 10 April 2025 Parth Vikram Singh talk contribs 40,798 bytes +1,137 No edit summary
• curprev 21:5721:57, 10 April 2025 Parth Vikram Singh talk contribs 39,661 bytes +1 No edit summary
• curprev 21:5621:56, 10 April 2025 Parth Vikram Singh talk contribs 39,660 bytes −138 No edit summary

4 April 2025

• curprev 10:2610:26, 4 April 2025 Parth Vikram Singh talk contribs 39,798 bytes +35 No edit summary
• curprev 10:1410:14, 4 April 2025 Parth Vikram Singh talk contribs 39,763 bytes +4 No edit summary
• curprev 09:5609:56, 4 April 2025 Parth Vikram Singh talk contribs 39,759 bytes −2 No edit summary Tag: Manual revert
• curprev 09:5309:53, 4 April 2025 Parth Vikram Singh talk contribs 39,761 bytes −2 No edit summary
• curprev 09:5209:52, 4 April 2025 Parth Vikram Singh talk contribs 39,763 bytes +4 No edit summary
• curprev 09:3909:39, 4 April 2025 Parth Vikram Singh talk contribs 39,759 bytes +1,351 No edit summary
• curprev 09:2509:25, 4 April 2025 Parth Vikram Singh talk contribs 38,408 bytes +3,137 No edit summary
• curprev 09:2309:23, 4 April 2025 Parth Vikram Singh talk contribs 35,271 bytes +758 No edit summary
• curprev 08:5708:57, 4 April 2025 Parth Vikram Singh talk contribs 34,513 bytes +4,378 No edit summary
• curprev 08:3208:32, 4 April 2025 Parth Vikram Singh talk contribs 30,135 bytes +847 No edit summary
• curprev 06:5706:57, 4 April 2025 Parth Vikram Singh talk contribs 29,288 bytes +2,020 No edit summary

3 April 2025

• curprev 18:4818:48, 3 April 2025 Parth Vikram Singh talk contribs 27,268 bytes +26,308 No edit summary
• curprev 17:1317:13, 3 April 2025 Parth Vikram Singh talk contribs 960 bytes +960 Created page with "{{DrugProjectFormSinglePage |authorTag=Parth Vikram Singh |indicationType=treatment |blackBoxWarningTitle='''<span style="color:#FF0000;">TITLE</span>''' |blackBoxWarningBody=''<span style="color:#FF0000;">Condition Name:</span>'' (Content) |offLabelAdultGuideSupport=There is limited information regarding ''Off-Label Guideline-Supported Use'' of Vorasidenib in adult patients. |offLabelAdultNoGuideSupport=There is limited information regarding ''Off-Label Non–Guideline-..."